CN103263507A - Non-tobacco snuff for treating rhinitis and nasal polyps, and preparation method thereof - Google Patents
Non-tobacco snuff for treating rhinitis and nasal polyps, and preparation method thereof Download PDFInfo
- Publication number
- CN103263507A CN103263507A CN2013101721845A CN201310172184A CN103263507A CN 103263507 A CN103263507 A CN 103263507A CN 2013101721845 A CN2013101721845 A CN 2013101721845A CN 201310172184 A CN201310172184 A CN 201310172184A CN 103263507 A CN103263507 A CN 103263507A
- Authority
- CN
- China
- Prior art keywords
- snuff
- tobacco
- radix
- preparation
- rhinitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention provides a non-tobacco snuff for treating the rhinitis and nasal polyps, and a preparation method thereof. The components of the non-tobacco snuff comprise Coffonrose Hibiscus Leaf, American ginseng, dahurian angelica root, Herba Centipedae, mint, lily magnolia, Nodus Nelumbinis Rhizomatis Charcoal, dried alum, Rubia cordifolia, borneol and borax. The preparation method comprises the following steps: respectively choosing Coffonrose Hibiscus Leaf, American ginseng or Radix Ginseng, dahurian angelica root, Herba Centipedae, mint, lily magnolia, Nodus Nelumbinis Rhizomatis Charcoal, dried alum, Rubia cordifolia; drying at a low temperature of 60DEG C to the water content of 5% or less; carrying out superfine crushing; respectively grinding borneol and borax, and sieving by a 200 mesh sieve; and mixing the above raw materials, uniformly stirring, and filling the obtained mixture to a bottle. The preparation method has the advantages of simplicity, easy operation and low preparation cost, and the produced non-tobacco snuff has the advantages of good effect, no toxic side effects, and very convenient use.
Description
[technical field]
The present invention relates to a kind of rhinitis, polypous snuff of non-tobacco and preparation method thereof for the treatment of.
[background technology]
Rhinitis and nasal polyp all are common chronic refractory diseases.The traditional Chinese medical science is thought: cause the exopathogen invasion and attack and rhinitis is many by the deficiency of vital energy is solid, heresy is gone into heat-transformation, and the saprophytic pus that burns is detained empty key, disperse empties, clear QI being mixed up with turbid QI and be disease.Rhinitis is protracted course of disease why, is easy to recurrence, its body deficient vital QI leading to lingering of pathogen that has its source in so, pathogenic factor is invaded for a long time, causes the body deficiency of vital QI, is difficult to resist the heresy of wind heat, wind and cold, so in the conversion in season, the disease of rhinitis is very easily recurrence just.Nasal polyp is the vegetation that betides nasal cavity, and the traditional Chinese medical science is called nasal polyp, nasal polyp many because of have a liking for the pungent savoury of food usually, accumulate give birth to damp and hot, on steam in lung, the knot nose key that stagnates, or wind-heat evil toxin attacks lung meridian, lung qi must not be declared freely, gathers the nose key and causes.Mainly showing as has one or more vegetations in the nose key, show smoothly, and color is light white or light red, softness of touching and not bitterly, having a stuffy nose with persistence, and hyposmia, nasal mucus increases, headache giddy etc.
At present, treat this common rhinitis, polypous active drug is limited, doctor trained in Western medicine generally adopts collunariums such as ephedrine collunarium or naphazoline liquid medicine, produces little effect; And adopt surgical excision for nasal polyp more, not only excision is clean but also relapse rate is high, brings bigger misery and financial burden to the patient.
[summary of the invention]
One of the technical problem to be solved in the present invention is to provide a kind of rhinitis, polypous snuff of non-tobacco for the treatment of, and this product cost is low, and is easy to use, and is effective and have no side effect.
The present invention is one of above-mentioned technical problem of realization like this:
A kind of rhinitis, polypous snuff of non-tobacco for the treatment of, the component of described snuff of non-tobacco is as follows: Folium Hibisci Mutabilis, Radix Panacis Quinquefolii, the Radix Angelicae Dahuricae, Herba Centipedae, Herba Menthae, Flos Magnoliae, charred Nodus Nelumbinis Rhizomatis, dried Alumen, Radix Rubiae, Borneolum Syntheticum and Borax.
Further, the percentage by weight of described each component of snuff of non-tobacco is as follows: Folium Hibisci Mutabilis 10-20%, Radix Panacis Quinquefolii or Radix Ginseng 5-10%, Radix Angelicae Dahuricae 10-20%, Herba Centipedae 10-20%, Herba Menthae 3-6%, Flos Magnoliae 10-20%, charred Nodus Nelumbinis Rhizomatis 5-10%, dried Alumen 3-6%, Radix Rubiae 10-15%, Borneolum Syntheticum 0.5-1% and Borax 0.5-1%.
Further, the order number of described each component of snuff of non-tobacco is more than 200 orders.
Two of the technical problem to be solved in the present invention, be to provide a kind of preparation method for the treatment of rhinitis, polypous snuff of non-tobacco, this preparation method is simple to operation, and preparation cost is low, and the snuff of non-tobacco of producing is effective and have no side effect, and is simultaneously very easy to use.
The present invention is two of the above-mentioned technical problem that realizes like this:
A kind of preparation method for the treatment of rhinitis, polypous snuff of non-tobacco, described preparation method is as follows:
Step 10, Folium Hibisci Mutabilis, Radix Panacis Quinquefolii or Radix Ginseng, the Radix Angelicae Dahuricae, Herba Centipedae, Herba Menthae, Flos Magnoliae, charred Nodus Nelumbinis Rhizomatis, dried Alumen, Radix Rubiae are chosen time respectively; Oven drying at low temperature is to moisture≤5% then; Carry out micronizing again;
Step 20, with Borneolum Syntheticum, Borax porphyrize respectively, after 200 mesh sieves;
Step 30, will be respectively mix and stir bottling at last through the raw material that step 10 is handled and step 20 is handled.
Further, the percentage by weight of described each component of snuff of non-tobacco is as follows: Folium Hibisci Mutabilis 10-20%, Radix Panacis Quinquefolii or Radix Ginseng 5-10%, Radix Angelicae Dahuricae 10-20%, Herba Centipedae 10-20%, Herba Menthae 3-6%, Flos Magnoliae 10-20%, charred Nodus Nelumbinis Rhizomatis 5-10%, dried Alumen 3-6%, Radix Rubiae 10-15%, Borneolum Syntheticum 0.5-1% and Borax 0.5-1%.
Further, the oven drying at low temperature temperature in the described step 10 is 60 ℃.
Further, in the described step 10, more than micronizing to 200 order.
The present invention has following advantage:
Advantage of the present invention is: easy to use, Folium Nicotianae preparatum is placed tiger, and also suck available cotton yarn with the nostril and be stained with a little Folium Nicotianae preparatum and fill in nasal cavity; Total effective rate is more than 100%, and cure rate is more than 95% and have no side effect; If no rhinitis, nasal polyp person also can be used as Folium Nicotianae preparatum at ordinary times and suck, play a role in health care, prevent medicated cigarette to the harm of human body and eliminated the pollution of smog to environment.
In a word, easy to use, the good effect of the present invention, therapeutic process is painless, can also alleviate patient's financial burden.
[specific embodiment]
The present invention relates to a kind of rhinitis, polypous snuff of non-tobacco for the treatment of, the component of described snuff of non-tobacco is as follows: Folium Hibisci Mutabilis, Radix Panacis Quinquefolii, the Radix Angelicae Dahuricae, Herba Centipedae, Herba Menthae, Flos Magnoliae, charred Nodus Nelumbinis Rhizomatis, dried Alumen, Radix Rubiae, Borneolum Syntheticum and Borax.
The order number of described each component of snuff of non-tobacco is more than 200 orders.
The invention still further relates to a kind of preparation method for the treatment of rhinitis, polypous snuff of non-tobacco, described preparation method is as follows:
Step 10, Folium Hibisci Mutabilis, Radix Panacis Quinquefolii or Radix Ginseng, the Radix Angelicae Dahuricae, Herba Centipedae, Herba Menthae, Flos Magnoliae, charred Nodus Nelumbinis Rhizomatis, dried Alumen, Radix Rubiae are chosen time respectively; Oven drying at low temperature is to moisture≤5% then; Carry out micronizing again;
Step 20, with Borneolum Syntheticum, Borax porphyrize respectively, after 200 mesh sieves;
Step 30, will be respectively mix and stir bottling at last through the raw material that step 10 is handled and step 20 is handled.
Oven drying at low temperature temperature in the described step 10 is 60 ℃.
In the described step 10, more than micronizing to 200 order.
The percentage by weight of described each component of snuff of non-tobacco is as follows: Folium Hibisci Mutabilis 10-20%, Radix Panacis Quinquefolii or Radix Ginseng 5-10%, Radix Angelicae Dahuricae 10-20%, Herba Centipedae 10-20%, Herba Menthae 3-6%, Flos Magnoliae 10-20%, charred Nodus Nelumbinis Rhizomatis 5-10%, dried Alumen 3-6%, Radix Rubiae 10-15%, Borneolum Syntheticum 0.5-1% and Borax 0.5-1%.
Below in conjunction with the explanation further of the present invention's do of embodiment.
Embodiment 1
Step 10, Folium Hibisci Mutabilis 18%, Radix Panacis Quinquefolii 8%, the Radix Angelicae Dahuricae 17%, Herba Centipedae 15%, Herba Menthae 4.5%, Flos Magnoliae 15%, charred Nodus Nelumbinis Rhizomatis 6%, dried Alumen 4%, Radix Rubiae 11% are chosen time respectively; Low temperature is dried to moisture≤5% for 60 ℃ then; Carry out micronizing again and cross 200 mesh sieves;
Step 20, Borneolum Syntheticum 0.6%, Borax 0.9% are ground to the powder respectively, after 200 mesh sieves;
Step 30, will be respectively mix and stir bottling at last through the raw material that step 10 is handled and step 20 is handled.
Embodiment 2
Step 10, Folium Hibisci Mutabilis 15%, Radix Panacis Quinquefolii 10%, the Radix Angelicae Dahuricae 15%, Herba Centipedae 18%, Herba Menthae 5%, Flos Magnoliae 16%, charred Nodus Nelumbinis Rhizomatis 5%, dried Alumen 5%, Radix Rubiae 10% are chosen time respectively; Low temperature is dried to moisture≤5% for 60 ℃ then; Carry out micronizing again and cross 200 mesh sieves;
Step 20, Borneolum Syntheticum 0.5%, Borax 0.5% are ground to the powder respectively, after 200 mesh sieves;
Step 30, will be respectively mix and stir bottling at last through the raw material that step 10 is handled and step 20 is handled.
Embodiment 3
Step 10, Folium Hibisci Mutabilis 13%, Radix Panacis Quinquefolii 9%, the Radix Angelicae Dahuricae 18%, Herba Centipedae 18.5%, Herba Menthae 3%, Flos Magnoliae 17%, charred Nodus Nelumbinis Rhizomatis 5%, dried Alumen 3%, Radix Rubiae 12% are chosen time respectively; Low temperature is dried to moisture≤5% for 60 ℃ then; Carry out micronizing again and cross 200 mesh sieves;
Step 20, Borneolum Syntheticum 0.7%, Borax 0.8% are ground to the powder respectively, after 200 mesh sieves;
Step 30, will be respectively mix and stir bottling at last through the raw material that step 10 is handled and step 20 is handled.
Below be medicinal effects analysis example of the present invention:
Case 1: Lin, woman, 40 years old, private owner, suffered from sinusitis 5 years, climate change whenever symptoms such as nasal obstruction, watery nasal discharge, olfactory sensation decline, dizziness just occur and shows effect repeatedly, medication every day 5 times, each about 0.2 gram sucks in the nose, and continuous use is after 7 days, transference cures such as nasal obstruction, olfactory disorder, dizziness were cured after 15 days.
Case 2: Yang, the woman, 14 years old, the student suffered from chronic allergic rhinitis 3 years, the repeated relapsing nasal dyspnea, olfactory disorder, headache, medication every day 3 times, each about 0.2 gram sucks in the nose, and continuous use is after 7 days, and above-mentioned symptom disappears, healing after 21 days.
Case 3: Zhang, man, 35 years old, teacher, suffered from left side nasal polyp, sinusitis 4 years, dyspnea, olfactory disorder, dizziness repeatedly, medication every day 3-5 time, each about 0.2 restrains, fill in the nose with the cotton yarn parcel, continuous use is the above-mentioned symptom disappearance after 10 days, cures after 25 days.
Case 4: the king so-and-so, the woman, 60 years old, the retired cadre, suffered from bilateral nasal polyp, hypertrophic inferior turbinate 5 years, dyspnea, olfactory sensation serious hindrance, substantially with mouth breathe, dizziness headache, medication every day 3-5 time, each about 0.2 restrains, fill in the nose with the cotton yarn parcel, after the medication 17 days, unimpeded, watery nasal discharge nasal obstruction disappearance that dizziness headache is alleviated, breathed, concha nasalis inferior swelling disappearance after 30 days, polyp disappear and fully recover.
Case 5: relax so-and-so, the woman, 10 years old, the student suffered from allergic rhinitis, sinusitis 2 years, had a stuffy nose, flows dense tears, dyspnea, snoring in bed, and medication every day 3 times, each about 0.2 gram sucks in the nose, and continuous use is after 7 days, and above-mentioned all diseases disappear, recovery from illness after 21 days.
Advantage of the present invention is: easy to use, Folium Nicotianae preparatum is placed tiger, and also suck available cotton yarn with the nostril and be stained with a little Folium Nicotianae preparatum and fill in nasal cavity; Total effective rate is more than 100%, and cure rate is more than 95% and have no side effect; If no rhinitis, nasal polyp person also can be used as Folium Nicotianae preparatum at ordinary times and suck, play a role in health care, prevent medicated cigarette to the harm of human body and eliminated the pollution of smog to environment.
In a word, easy to use, the good effect of the present invention, therapeutic process is painless, can also alleviate patient's financial burden.
Though more than described the specific embodiment of the present invention; but being familiar with those skilled in the art is to be understood that; our described specific embodiment is illustrative; rather than for the restriction to scope of the present invention; those of ordinary skill in the art are in modification and the variation of the equivalence of doing according to spirit of the present invention, all should be encompassed in the scope that claim of the present invention protects.
Claims (7)
1. treat rhinitis, polypous snuff of non-tobacco for one kind, it is characterized in that: the component of described snuff of non-tobacco is as follows: Folium Hibisci Mutabilis, Radix Panacis Quinquefolii, the Radix Angelicae Dahuricae, Herba Centipedae, Herba Menthae, Flos Magnoliae, charred Nodus Nelumbinis Rhizomatis, dried Alumen, Radix Rubiae, Borneolum Syntheticum and Borax.
2. a kind of rhinitis, polypous snuff of non-tobacco for the treatment of as claimed in claim 1, it is characterized in that: the percentage by weight of described each component of snuff of non-tobacco is as follows: Folium Hibisci Mutabilis 10-20%, Radix Panacis Quinquefolii or Radix Ginseng 5-10%, Radix Angelicae Dahuricae 10-20%, Herba Centipedae 10-20%, Herba Menthae 3-6%, Flos Magnoliae 10-20%, charred Nodus Nelumbinis Rhizomatis 5-10%, dried Alumen 3-6%, Radix Rubiae 10-15%, Borneolum Syntheticum 0.5-1% and Borax 0.5-1%.
3. a kind of rhinitis, polypous snuff of non-tobacco for the treatment of as claimed in claim 1 or 2, it is characterized in that: the order number of described each component of snuff of non-tobacco is more than 200 orders.
4. preparation method for the treatment of rhinitis, polypous snuff of non-tobacco, it is characterized in that: described preparation method is as follows:
Step 10, Folium Hibisci Mutabilis, Radix Panacis Quinquefolii or Radix Ginseng, the Radix Angelicae Dahuricae, Herba Centipedae, Herba Menthae, Flos Magnoliae, charred Nodus Nelumbinis Rhizomatis, dried Alumen, Radix Rubiae are chosen time respectively; Oven drying at low temperature is to moisture≤5% then; Carry out micronizing again;
Step 20, with Borneolum Syntheticum, Borax porphyrize respectively, after 200 mesh sieves;
Step 30, will be respectively mix and stir bottling at last through the raw material that step 10 is handled and step 20 is handled.
5. a kind of preparation method for the treatment of rhinitis, polypous snuff of non-tobacco according to claim 4, it is characterized in that: the percentage by weight of described each component of snuff of non-tobacco is as follows: Folium Hibisci Mutabilis 10-20%, Radix Panacis Quinquefolii or Radix Ginseng 5-10%, Radix Angelicae Dahuricae 10-20%, Herba Centipedae 10-20%, Herba Menthae 3-6%, Flos Magnoliae 10-20%, charred Nodus Nelumbinis Rhizomatis 5-10%, dried Alumen 3-6%, Radix Rubiae 10-15%, Borneolum Syntheticum 0.5-1% and Borax 0.5-1%.
6. a kind of preparation method for the treatment of rhinitis, polypous snuff of non-tobacco according to claim 5, it is characterized in that: the oven drying at low temperature temperature in the described step 10 is 60 ℃.
7. a kind of preparation method for the treatment of rhinitis, polypous snuff of non-tobacco according to claim 6 is characterized in that: in the described step 10, more than micronizing to 200 order.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101721845A CN103263507A (en) | 2013-05-10 | 2013-05-10 | Non-tobacco snuff for treating rhinitis and nasal polyps, and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101721845A CN103263507A (en) | 2013-05-10 | 2013-05-10 | Non-tobacco snuff for treating rhinitis and nasal polyps, and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103263507A true CN103263507A (en) | 2013-08-28 |
Family
ID=49007201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013101721845A Pending CN103263507A (en) | 2013-05-10 | 2013-05-10 | Non-tobacco snuff for treating rhinitis and nasal polyps, and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103263507A (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104815284A (en) * | 2015-03-28 | 2015-08-05 | 繁昌县智融中药材专业合作社 | Traditional Chinese medicinal composition for treating nasal polyp |
| CN106993822A (en) * | 2017-06-12 | 2017-08-01 | 四川三联新材料有限公司 | One kind smells cigarette and smells cigarette component |
| CN108420102A (en) * | 2018-02-22 | 2018-08-21 | 四川艾施派尔新材料科技有限公司 | A kind of cigarette composition and technique for treating rhinitis |
| CN110448674A (en) * | 2019-08-16 | 2019-11-15 | 河南壹哆康健康科技有限公司 | For treating concha hypertrophy, powder of nasal polyp and preparation method thereof |
| US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
| US11672862B2 (en) | 2019-12-09 | 2023-06-13 | Nicoventures Trading Limited | Oral products with reduced irritation |
| US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
| US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
| US11839602B2 (en) | 2020-11-25 | 2023-12-12 | Nicoventures Trading Limited | Oral cannabinoid product with lipid component |
| US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
| US11883527B2 (en) | 2019-12-09 | 2024-01-30 | Nicoventures Trading Limited | Oral composition and method of manufacture |
| US11889856B2 (en) | 2019-12-09 | 2024-02-06 | Nicoventures Trading Limited | Oral foam composition |
| US11896711B2 (en) | 2019-12-09 | 2024-02-13 | Nicoventures Trading Limited | Process of making nanoemulsion |
| US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
-
2013
- 2013-05-10 CN CN2013101721845A patent/CN103263507A/en active Pending
Non-Patent Citations (5)
| Title |
|---|
| 张常喜等: "《回医绿茶疏风方治疗过敏性鼻炎48例临床分析》", 《中国中医基础医学杂志》 * |
| 徐静: "《鼻炎选方用药临床经验介绍》", 《第15届全国中医耳鼻喉科学术研讨和继续教育年会论文汇编》 * |
| 田彦科等: "《鼻息肉栓剂治疗鼻息肉》", 《中医外治杂志》 * |
| 程爵棠: "《鼻渊散外治鼻渊》", 《四川中医》 * |
| 黄依雯等: "《枯矾的临床应用研究进展》", 《中国药房》 * |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104815284A (en) * | 2015-03-28 | 2015-08-05 | 繁昌县智融中药材专业合作社 | Traditional Chinese medicinal composition for treating nasal polyp |
| CN106993822A (en) * | 2017-06-12 | 2017-08-01 | 四川三联新材料有限公司 | One kind smells cigarette and smells cigarette component |
| CN108420102A (en) * | 2018-02-22 | 2018-08-21 | 四川艾施派尔新材料科技有限公司 | A kind of cigarette composition and technique for treating rhinitis |
| CN110448674A (en) * | 2019-08-16 | 2019-11-15 | 河南壹哆康健康科技有限公司 | For treating concha hypertrophy, powder of nasal polyp and preparation method thereof |
| US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
| US11672862B2 (en) | 2019-12-09 | 2023-06-13 | Nicoventures Trading Limited | Oral products with reduced irritation |
| US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
| US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
| US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
| US11883527B2 (en) | 2019-12-09 | 2024-01-30 | Nicoventures Trading Limited | Oral composition and method of manufacture |
| US11889856B2 (en) | 2019-12-09 | 2024-02-06 | Nicoventures Trading Limited | Oral foam composition |
| US11896711B2 (en) | 2019-12-09 | 2024-02-13 | Nicoventures Trading Limited | Process of making nanoemulsion |
| US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
| US11839602B2 (en) | 2020-11-25 | 2023-12-12 | Nicoventures Trading Limited | Oral cannabinoid product with lipid component |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103263507A (en) | Non-tobacco snuff for treating rhinitis and nasal polyps, and preparation method thereof | |
| CN104013864A (en) | Traditional Chinese medicine composition for treating bronchitis | |
| CN101816736B (en) | Chinese medicament capsule for curing nasosinusitis | |
| CN103463584B (en) | Peptic ulcer treatment traditional Chinese medicine composition and preparation method thereof | |
| CN104840734B (en) | Clearing health-care Chinese medicinal composition and its preparation method and application | |
| CN106668631A (en) | Chinese herbal medicine for treating rhinitis | |
| CN1317004C (en) | Chinese medicine prepn for treating infantile respiratory tract infection | |
| CN103041129B (en) | Traditional Chinese medicine composition for treating pneumonia | |
| CN107158214A (en) | A kind of antibacterial cold dispelling rhinitis ointment and preparation method thereof | |
| CN102743732B (en) | Chinese medicine damp-hot compress bag for treating hyperosteogeny | |
| CN102357127A (en) | Chinese herbal medicine for treating influenza | |
| CN102743568B (en) | Traditional Chinese medicine composite for treating acute gangrenous stomatitis | |
| CN104906440A (en) | Traditional Chinese medicine for acute nasopharyngitis treatment | |
| CN103110774A (en) | Chinese herbal preparation for treating epistaxis and preparation method thereof | |
| CN103341151B (en) | Traditional Chinese medicine for treating chronic bronchitis | |
| CN107158078A (en) | Special efficacy Chinese herb medicine powder for rhinitis and rhinitis ointment | |
| CN106540107A (en) | A kind of prescription for treating infantile pneumonia | |
| CN103585450A (en) | Drug composition for treating chronic pharyngitis | |
| CN104998211A (en) | Application of medicine composition to cervical spondylosis treatment | |
| CN108030842A (en) | A kind of Chinese medicine for treating rectitis | |
| CN104547718B (en) | A kind of pharmaceutical composition preventing and treating fracture of children internal fixation postoperative infection | |
| CN104208365B (en) | Traditional Chinese medicine preparation of external oxygenation pill, and preparation and using methods thereof | |
| CN103989744A (en) | Medicinal liquor for treating fracture as well as preparation method and application of medicinal liquor | |
| CN103536821B (en) | A kind of Chinese patent pills for the treatment of chronic rhinitis | |
| CN1739540A (en) | Application of arctiin in preparing medicine for treating rhinitis and nasosinusitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130828 |